Asbestos and Health
A special issue of International Journal of Environmental Research and Public Health (ISSN 1660-4601). This special issue belongs to the section "Environmental Health".
Deadline for manuscript submissions: closed (30 November 2020) | Viewed by 17023
Special Issue Editor
2. Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, WA 6009, Australia
Interests: clinical and epidemiological aspects of respiratory diseases and cancer particularly occupational diseases and especially asbestos related diseases
* Passed away on 3 November 2021
Special Issue Information
Dear Colleagues,
"Asbestos" is a term applied to a group of minerals that have been widely used in construction and industry over the past century because of their physical properties: strong and indestructible fibers that are valuable for creating heat-resistant and resilient building sheets, and heat insulation for boilers and furnaces and other machinery. Exposure to airborne asbestos fibers occurs in its mining and transport, and during its use in industry and construction, most recently during the renovation or removal of existing asbestos structures, and environmentally from the deterioration of asbestos in situ.
The fibrous shape of air-borne asbestos particles determines their passage through the airways when they are inhaled and their resistance to clearance from the lungs when they have been deposited in the conducting airways or the gas-exchanging lung parenchyma as far as the pleura. They also disseminate in the body through lymphatic and circulatory pathways, where they persist. As a result of this they cause inflammatory and neoplastic responses in the airways and lung parenchyma and pleura: asbestosis, respiratory cancer of all varieties (especially in tobacco smokers), malignant mesothelioma (pleural and peritoneal), benign pleural effusions, and diffuse pleural thickening. Asbestos fibers are persistent in the tissues of the body, and the diseases that result from their inhalation often do not occur until years or decades have passed. Thus, the attribution of disease to asbestos exposure was slow to evolve and epidemiological studies have been critical to their understanding, and laboratory studies of asbestos exposure have contributed to understanding the process of carcinogenesis at a cellular level.
There has been an epidemic of litigation for asbestos-related disease compensation with legal implications, and the input of physicians and epidemiologists have been critical to the successful outcome of these legal cases.
Advances in chemotherapy and immunotherapy have recently been important in the treatment of asbestos-related malignancies and the extension of patient survival.
Prof. Arthur W. (Bill) Musk
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Asbestos
- Asbestosis
- Mesothelioma
- Lung cancer
- Pleural effusion
- Pleural fibrosis/thickening
- Immunotherapy
- Chemotherapy
- Epidemiology
- Litigation/compensation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.